Perceptive Advisors closes USD515m Perceptive Xontogeny Venture Fund II
Perceptive Advisors, an investment management firm focused on the life sciences sector, has held the first and final closing of Perceptive Xontogeny Venture Fund II (PXV Fund II) with USD515 million in capital commitments. The close of PXV Fund II more than triples the firm’s assets under management to USD725
